Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2
Open Access
- 14 March 2020
- preprint content
- Published by Cold Spring Harbor Laboratory
Abstract
A global pandemic of Corona Virus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome CoV-2 (SARS-CoV-2) is ongoing spread. It remains unclear whether the convalescing patients have a risk of reinfection. Rhesus macaques were rechallenged with SARS-CoV-2 during an early recovery phase from initial infection characterized by weight loss, interstitial pneumonia and systemic viral dissemination mainly in respiratory and gastrointestinal tracts. The monkeys rechallenged with the identical SARS-CoV-2 strain have failed to produce detectable viral dissemination, clinical manifestations and histopathological changes. A notably enhanced neutralizing antibody response might contribute the protection of rhesus macaques from the reinfection by SARS-CoV-2. Our results indicated that primary SARS-CoV-2 infection protects from subsequent reinfection.One Sentence SummaryNeutralizing antibodies against SARS-CoV-2 might protect rhesus macaques which have undergone an initial infection from reinfection during early recovery days.Keywords
This publication has 8 references indexed in Scilit:
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate modelScience, 2020
- Positive RT-PCR Test Results in Patients Recovered From COVID-19Jama-Journal Of The American Medical Association, 2020
- Comparison of SARS-CoV-2 infections among 3 species of non-human primatesPublished by Cold Spring Harbor Laboratory ,2020
- Age‐related rhesus macaque models of COVID‐19Animal Models and Experimental Medicine, 2020
- Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA testPublished by Cold Spring Harbor Laboratory ,2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their ImplicationsSSRN Electronic Journal, 2020
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteinsBiochemical and Biophysical Research Communications, 2014